Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Asses the Safety and Efficacy of Once-Daily KRP-104 in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin Alone.

NCT00995345 is registered in ClinicalTrials.gov with ActivX Biosciences, Inc. as lead sponsor.

NCT NCT00995345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00995345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Asses the Safety and Efficacy of Once-Daily KRP-104 in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin Alone.
Lead sponsor
ActivX Biosciences, Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2009
Completion date
January 31, 2011
Enrollment
403 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes